Table 1 The clinical characteristics of all patients (n = 551)
Characteristics | Patients |
|---|---|
Age(y) | 61 (53–68) |
Gender | |
Male | 383 (69.5%) |
Female | 168 (30.5%) |
Smoking history | |
Y | 355 (64.4%) |
N | 196 (35.6%) |
Stage | |
I-II | 354 (64.2%) |
IIIA | 197 (35.8%) |
Pathological tumor | |
classification (pT) | |
pT1–2 | 475 (86.2%) |
pT3–4 | 76 (13.8%) |
Pathological lymph node | |
stage (pN) | |
pN0 | 298 (54.1%) |
pN1–2 | 253 (45.9%) |
Histological type | |
Squamous cell carcinoma | 174 (31.6%) |
Adenocarcinoma | 329 (59.7%) |
Large cell carcinoma | 48 (8.7%) |
Surgery type | |
Lobectomy | 395 (71.7%) |
Pneumonectomy | 120 (21.8%) |
Other | 36 (6.5%) |
Adjuvant chemotherapy | |
Y | 299 (54.3%) |
N | 252 (45.7%) |
GLU (mmol/L) | 5.27 (4.78–5.88) |
TC (mmol/L) | 4.20 (3.63–4.89) |
TG (mmol/L) | 1.09 (0.80–1.72) |
HDL-C (mmol/L) | 1.17 (0.97–1.40) |
LDL-C (mmol/L) | 2.55 (2.08–3.08) |
ApoA1(g/L) | 1.15 (1.01–1.29) |
Apo B(g/L) | 0.85 (0.71–1.02) |
Lpa (mg/L) | 189 (90–408) |